Dipace Concetta, Sung Uhna, Binda Francesca, Blakely Randy D, Galli Aurelio
Department of Molecular Physiology and Biophysics, Center for Molecular Neuroscience, Vanderbilt University Medical Center, 465 21st Avenue South, 7124A Medical Research Building III, Nashville, TN 37232, USA.
Mol Pharmacol. 2007 Jan;71(1):230-9. doi: 10.1124/mol.106.026690. Epub 2006 Oct 10.
Norepinephrine (NE) transporters (NETs) are high-affinity transport proteins that mediate the synaptic clearance of NE after vesicular release. NETs represent a major therapeutic target for antidepressants and are targets of multiple psychostimulants including amphetamine (AMPH) and cocaine. Recently, we demonstrated that syntaxin 1A (SYN1A) regulates NET surface expression and, through binding to the transporter's NH(2) terminus, regulates transporter catalytic function. AMPH induces NE efflux and may also regulate transporter trafficking. We monitored NET distribution and function in catecholaminergic cell lines (CAD) stably transfected with either full-length human NET (CAD-hNET) or with an hNET N-terminal deletion (CAD-hNETDelta(28-47) cells). In hNET-CAD cells, AMPH causes a slow and small reduction of surface hNET with a modest increase in hNET/SYN1A associations at the plasma membrane. In contrast, in CAD-hNETDelta(28-47) cells, AMPH induces a rapid and substantial reduction in surface hNETDelta(28-47) accompanied by a large increase in plasma membrane hNETDelta(28-47)/SYN1A complexes. We also found that AMPH in CAD-hNETDelta(28-47) cells induces a robust increase in cytosolic Ca2+ and concomitant activation of calcium/calmodulin-dependent protein kinase II (CaMKII). Inhibition of either the increase in intracellular Ca2+ or CaMKII activity blocks AMPH-stimulated hNETDelta(28-47) trafficking and the formation of hNETDelta(28-47)/SYN1A complexes. Here, we demonstrate that AMPH stimulation of CAMKII stabilizes an hNET/SYN1A complex. This hNET/SYN1A complex rapidly redistributes, upon AMPH treatment, when mechanisms supported by the transporter's NH2 terminus are eliminated.
去甲肾上腺素(NE)转运体(NETs)是高亲和力转运蛋白,可介导囊泡释放后NE的突触清除。NETs是抗抑郁药的主要治疗靶点,也是包括苯丙胺(AMPH)和可卡因在内的多种精神兴奋剂的作用靶点。最近,我们证明了 syntaxin 1A(SYN1A)调节NET的表面表达,并通过与转运体的NH(2)末端结合来调节转运体的催化功能。AMPH诱导NE外流,也可能调节转运体的转运。我们监测了稳定转染全长人NET(CAD-hNET)或hNET N末端缺失(CAD-hNETDelta(28-47)细胞)的儿茶酚胺能细胞系(CAD)中NET的分布和功能。在hNET-CAD细胞中,AMPH导致表面hNET缓慢且小幅减少,同时质膜上hNET/SYN1A结合适度增加。相比之下,在CAD-hNETDelta(28-47)细胞中,AMPH诱导表面hNETDelta(28-47)迅速且大幅减少,同时质膜上hNETDelta(28-47)/SYN1A复合物大量增加。我们还发现,CAD-hNETDelta(28-47)细胞中的AMPH诱导胞质Ca2+强烈增加,并伴随钙/钙调蛋白依赖性蛋白激酶II(CaMKII)的激活。抑制细胞内Ca2+增加或CaMKII活性可阻断AMPH刺激的hNETDelta(28-47)转运以及hNETDelta(28-47)/SYN1A复合物的形成。在此,我们证明了AMPH对CAMKII的刺激使hNET/SYN1A复合物稳定。当转运体NH2末端支持的机制被消除时,这种hNET/SYN1A复合物在AMPH处理后会迅速重新分布。